{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T05:12:14Z","timestamp":1737090734465,"version":"3.33.0"},"reference-count":25,"publisher":"Galenos Yayinevi","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjps"],"published-print":{"date-parts":[[2023,12,27]]},"DOI":"10.4274\/tjps.galenos.2023.44675","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T08:12:10Z","timestamp":1703664730000},"page":"0-0","source":"Crossref","is-referenced-by-count":0,"title":["Initial Empirical Antibiotic Treatment in Covid-19 Patients is Related with Excess Adverse Drug Reactions Without Clinical Benefit"],"prefix":"10.4274","volume":"0","author":[{"given":"P\u0131nar Bak\u0131r","family":"EK\u0130NC\u0130","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"KARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gu\u0308l\u00e7in","family":"TELL\u0130 D\u0130ZMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meliha \u00c7a\u011fla","family":"S\u00d6NMEZER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet \u00c7a\u011fkan","family":"\u0130NKAYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kutay","family":"DEM\u0130RKAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serhat","family":"\u00dcNAL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6mru\u0308m","family":"UZUN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2023,12,27]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cmi.2020.09.041","article-title":"Recommendations for antibacterial therapy in adults with COVID-19-an evidence based guideline","volume":"27","author":"Sieswerda","year":"2021","unstructured":"1. Sieswerda E, de Boer MGJ, Bonten MMJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, Schouten JA, van de Garde EMW, Verheij TJ, van der Eerden MM, Prins JM, Wiersinga WJ. Recommendations for antibacterial therapy in adults with COVID-19-an evidence based guideline. Clin Microbiol Infect. 2021;27:61-66.","journal-title":"Clin Microbiol Infect"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12879-021-06219-z","article-title":"Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission","volume":"21","author":"Pettit","year":"2021","unstructured":"2. Pettit NN, Nguyen CT, Lew AK, Bhagat PH, Nelson A, Olson G, Ridgway JP, Pho MT, Pagkas-Bather J. Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission. BMC Infect Dis. 2021;21:516.","journal-title":"BMC Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1001\/jama.2020.3204","article-title":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore","volume":"323","author":"BE","year":"2020","unstructured":"3. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, Ng OT, Marimuthu K, Ang LW, Mak TM, Lau SK, Anderson DE, Chan KS, Tan TY, Ng TY, Cui L, Said Z, Kurupatham L, Chen MI, Chan M, Vasoo S, Wang LF, Tan BH, Lin RTP, Lee VJM, Leo YS, Lye DC; Singapore 2019 Novel Coronavirus Outbreak Research Team. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323:1488-1494.","journal-title":"JAMA"},{"key":"ref3","unstructured":"4. World Health Organization (WHO) Living Guidance for Clinical Management of COVID-19: Living Guidance. Nov 23, 2021. [Accessed on 23 July 2022]. Available: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-clinical-2021-2"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Evans TJ, Davidson HC, Low JM, Basarab M, Arnold A. Antibiotic usage and stewardship in patients with COVID-19: too much antibiotic in uncharted waters? J Infect Prev. 2021;22:119-125.","DOI":"10.1177\/1757177420976813"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3906\/sag-2006-173","article-title":"Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU","volume":"51","author":"\u00c7al\u0131k Ba\u015faran","year":"2021","unstructured":"6. \u00c7al\u0131k Ba\u015faran N, Uyaro\u011flu OA, Telli Dizman G, \u00d6z\u0131\u015f\u0131k L, \u015eahin TK, Ta\u015f Z, \u0130nkaya A\u00c7, Karahan S, Alp \u015e, Alp A, Metan G, Zarakol P, Sain G\u00fcven G, \u00d6z \u015eG, Topeli A, Uzun \u00d6, Akova M, \u00dcnal S. Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU. Turk J Med Sci. 2021;51:411-420.","journal-title":"Turk J Med Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","article-title":"Bacterial and fungal coinfection in individuals with Coronavirus: a rapid review to support COVID-19 antimicrobial prescribing","volume":"71","author":"Rawson","year":"2020","unstructured":"7. Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A. Bacterial and fungal coinfection in individuals with Coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71:2459-2468.","journal-title":"Clin Infect Dis"},{"key":"ref7","unstructured":"8. \u0130la\u00e7 End\u00fcstrisi \u0130\u015fverenler Sendikas\u0131 (\u0130E\u0130S)-Temel G\u00f6stergeler\/T\u00fcrkiye \u0130la\u00e7 Pazar\u0131: - n.d. [Accessed on May 26, 2023]. Available: http:\/\/ieis.org.tr\/ieis\/tr\/indicators\/33\/turkiye-ilac-pazari"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4274\/balkanmedj.galenos.2022.2021-11-62","article-title":"Antibiotic use and Influencing factors among hospitalized patients with COVID-19: A multicenter point-prevalence study from Turkey","volume":"39","author":"\u015eencan \u0130","year":"2022","unstructured":"9. \u015eencan \u0130, \u00c7a\u011f Y, Karabay O, Kurtaran B, G\u00fc\u00e7l\u00fc E, \u00d6\u011f\u00fctl\u00fc A, Demirba\u015f Z, Bulut D, Karl\u0131da\u011f GE, Sefa Sayar M, \u015eibar EG, Eren Kutsoylu O\u00d6, Kul G, Erol S, Bekta\u015f B, \u00dcnver Ulusoy T, Kuzi S, Tasbakan M, Yi\u011fit \u00d6, Ceran N, \u0130nal AS, Ergen P, Yamazhan T, Uzar H, A\u011falar C. Antibiotic use and Influencing factors among hospitalized patients with COVID-19: A multicenter point-prevalence study from Turkey. Balkan Med J. 2022;39:209-217.","journal-title":"Balkan Med J"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/2042098614554919","article-title":"Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem","volume":"5","author":"Llor","year":"2014","unstructured":"10. Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5:229-241.","journal-title":"Ther Adv Drug Saf"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.5578\/mb.20219815","article-title":"Evaluation of a Visually-Read Rapid Antigen Test Kit (SGA V-Chek) for detection of SARS-CoV-2 virus","volume":"55","author":"Kipritci","year":"2021","unstructured":"11. Kipritci Z, Keskin AU, Ciragil P, Topkaya AE. Evaluation of a Visually-Read Rapid Antigen Test Kit (SGA V-Chek) for detection of SARS-CoV-2 virus. Mikrobiyol Bul. 2021;55:461-464.","journal-title":"Mikrobiyol Bul"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"104468","DOI":"10.1016\/j.jcv.2020.104468","article-title":"Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies","volume":"129","author":"Beavis","year":"2020","unstructured":"12. Beavis KG, Matushek SM, Abeleda APF, Bethel C, Hunt C, Gillen S, Moran A, Tesic V. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies. J Clin Virol. 2020;129:104468.","journal-title":"J Clin Virol"},{"key":"ref12","unstructured":"13. Gomes C. Report of the World Health Organization (WHO)-China joint mission on Coronavirus Disease 2019 (COVID-19). Braz J Implantol Health Sci. 2020;2."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)","volume":"17","author":"JA","year":"2013","unstructured":"14. Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17:204.","journal-title":"Crit Care"},{"key":"ref14","unstructured":"15. LiverTox: Clinical and research information on drug-induced liver injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Severity grading in drug induced liver injury. May 4, 2019. [Accessed on 25 November 2023]. Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548241\/"},{"key":"ref15","unstructured":"16. Gilbert DN, Robert C, Moellering JMD, Eliopoulos GM, Sande MA. The Sanford guide to antimicrobial therapy: Antimicrobial therapy. 2011;40:48-51."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","unstructured":"17. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934-943.","journal-title":"JAMA Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","unstructured":"18. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","unstructured":"19. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-513.","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/cid\/ciaa272","article-title":"Clinical features of 69 cases with Coronavirus Disease 2019 in Wuhan, China","volume":"71","author":"Wang","year":"2020","unstructured":"20. Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. 2020;71:769-777.","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","unstructured":"21. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062.","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cid\/ciaa902","article-title":"Community-acquired coinfection in Coronavirus Disease 2019: A retrospective observational experience","volume":"72","author":"Lehmann","year":"2021","unstructured":"22. Lehmann CJ, Pho MT, Pitrak D, Ridgway JP, Pettit NN. Community-acquired coinfection in Coronavirus Disease 2019: A retrospective observational experience. Clin Infect Dis. 2021;72:1450-1452.","journal-title":"Clin Infect Dis"},{"key":"ref22","unstructured":"23. Telli Dizman G, Metan G, Ayaz Ceylan \u00c7M, Altunay H, Uzun M, G\u00fcrsoy G, Ta\u015f Z, Karahan G, Ahmadova F, Sar\u0131cao\u011flu T, \u00c7al\u0131\u015fkan ZC, Alp A, S\u00f6nmezler M, \u0130nkaya A, \u00d6zyavuz Alp \u015e, Uyaro\u011flu O, Er A, \u00d6zyavuz Alp \u015e, Uyaro\u011flu O, Durusu Tanri\u00f6ver M, \u00c7al\u0131k Ba\u015faran N, Durhan G, Demirkaz\u0131k F. A COVID-19 first evaluation clinic at a university hospital in Turkey. Turk J Med Sci. 2022;52:1-10."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1093\/jac\/dkaa326","article-title":"Antibiotic use in patients with COVID-19: a 'snapshot' Infectious Diseases International Research Initiative (ID-IRI) survey","volume":"75","author":"Beovi\u0107","year":"2020","unstructured":"24. Beovi\u0107 B, Dou\u0161ak M, Ferreira-Coimbra J, Nadrah K, Rubulotta F, Belliato M, Berger-Estilita J, Ayoade F, Rello J, Erdem H. Antibiotic use in patients with COVID-19: a 'snapshot' Infectious Diseases International Research Initiative (ID-IRI) survey. J Antimicrob Chemother. 2020;75:3386-3390.","journal-title":"J Antimicrob Chemother"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Ng TM, Ong SWX, Loo AYX, Tan SH, Tay HL, Yap MY, Lye DC, Lee TH, Young BE. Antibiotic therapy in the treatment of COVID-19 Pneumonia: Who and when? Antibiotics. 2022;11:184.","DOI":"10.3390\/antibiotics11020184"}],"container-title":["Turkish Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T06:54:10Z","timestamp":1737010450000},"score":1,"resource":{"primary":{"URL":"https:\/\/turkjps.org\/articles\/doi\/tjps.galenos.2023.44675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,27]]},"references-count":25,"journal-issue":{"issue":"0","published-online":{"date-parts":[[2023,12,27]]},"published-print":{"date-parts":[[2023,12,27]]}},"URL":"https:\/\/doi.org\/10.4274\/tjps.galenos.2023.44675","relation":{},"ISSN":["1304-530X","2148-6247"],"issn-type":[{"type":"print","value":"1304-530X"},{"type":"electronic","value":"2148-6247"}],"subject":[],"published":{"date-parts":[[2023,12,27]]}}}